Effect of raloxifene on fractures in postmenopausal women with or at risk for coronary heart disease: The raloxifene use for the heart (RUTH) study

被引：0
|
作者：
Ensrud, Kristine E.
Stock, John L.
Grady, Deborah
Barrett-Connor, Elizabeth
Mosca, Lori
Khaw, Kay-Tee
Zhao, Qingwen
Agnusdei, Donato
Dalsky, Gail P.
Cauley, Jane A.
机构：
[1] VAMC, Minneapolis, MN USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
[6] Columbia Univ, Med Ctr, New York, NY USA
[7] Univ Cambridge, Sch Clin Med, Cambridge, England
[8] Eli Lilly & Co, Burlington, CT USA
[9] Univ Pittsburgh, Pittsburgh, PA USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S234 / S235
页数：2
相关论文
共 50 条
  • [1] Effects of raloxifene on fracture risk in postmenopausal women: The raloxifene use for the heart trial
    Ensrud, Kristine E.
    Stock, John L.
    Barrett-Connor, Elizabeth
    Grady, Deborah
    Mosca, Lori
    Khaw, Kay-Tee
    Zhao, Qingwen
    Agnusdei, Donato
    Cauley, Jane A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (01) : 112 - 120
  • [2] Is Diabetes Mellitus a Heart Disease Equivalent in Women? Results From an International Study of Postmenopausal Women in the Raloxifene Use for the Heart (RUTH) Trial
    Daniels, Lori B.
    Grady, Deborah
    Mosca, Lori
    Collins, Peter
    Mitlak, Bruce H.
    Amewou-Atisso, Messan G.
    Wenger, Nanette K.
    Barrett-Connor, Elizabeth
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (02): : 164 - +
  • [3] Risk of stroke in the raloxifene use for the heart (RUTH) trial
    Mosca, Lori
    Grady, Deborah
    Barrett-Connor, Elizabeth
    Collins, Peter
    Wenger, Nanette
    Geiger, Mary Jane
    Amewou-Atisso, Messan
    Lilly, Eli
    Kornitzer, Marcel
    CIRCULATION, 2006, 114 (18) : 444 - 444
  • [4] Effect of coronary heart disease (CHD) risk factors and medications on invasive breast cancer risk in the Raloxifene Use for The Heart (RUTH) trial
    Mershon, J.
    Geiger, M.
    Barrett-Connor, E.
    Collins, P.
    Kornitzer, M.
    Dowsett, S.
    Zheng, S.
    Song, J.
    Wenger, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Design and methods of the raloxifene use for the heart (RUTH) study
    Mosca, L
    Barrett-Connor, E
    Wenger, NK
    Collins, P
    Grady, D
    Kornitzer, M
    Moscarelli, E
    Paul, S
    Wright, TJ
    Helterbrand, JD
    Anderson, PW
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (04): : 392 - 395
  • [6] Effect of raloxifene on heart rate variability in postmenopausal women
    George, ZH
    Chamoun, C
    Groh, W
    von der Lohe, E
    CIRCULATION, 2005, 111 (04) : E60 - E60
  • [7] Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart Disease
    Mosca, Lori
    Grady, Deborah
    Barrett-Connor, Elizabeth
    Collins, Peter
    Wenger, Nanette
    Abramson, Beth L.
    Paganini-Hill, Annlia
    Geiger, Mary Jane
    Dowsett, Sherie A.
    Amewou-Atisso, Messan
    Kornitzer, Marcel
    STROKE, 2009, 40 (01) : 147 - 155
  • [8] Rationale and overview of the Raloxifene Use for the Heart (RUTH) trial
    Mosca, L
    SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 181 - 185
  • [9] Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial
    Wenger, NK
    Barrett-Connor, E
    Collins, P
    Grady, D
    Kornitzer, M
    Mosca, L
    Sashegyi, A
    Baygani, SK
    Anderson, PW
    Moscarelli, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (11): : 1204 - 1210
  • [10] Antiplatelet Therapy Use and the Risk of Venous Thromboembolic Events in the Raloxifene Use for the Heart (RUTH) Trial
    Duvernoy, Claire S.
    Yeo, Adeline A.
    Wong, Mayme
    Cox, David A.
    Kim, Hyungjin M.
    JOURNAL OF WOMENS HEALTH, 2010, 19 (08) : 1459 - 1465
12345